News
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Gilead researchers and collaborators will present new Phase 3 ...
The World Health Organization (WHO) on Monday recommended countries to use the twice-a-year lenacapavir injection as an add ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback